Krystal Biotech (KRYS) Shares Outstanding (Weighted Average) (2016 - 2026)
Krystal Biotech recorded quarterly Shares Outstanding (Weighted Average) of $29.3 million in Q1 2026, up 1.19% quarter-over-quarter from $28.9 million in Q4 2025, and up 1.64% year-over-year from $28.8 million in Q1 2025.
Krystal Biotech's Shares Outstanding (Weighted Average) history runs 11 years deep, the most recent figure standing at $29.3 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) rose 1.64% year-over-year to $29.3 million; the TTM figure through Mar 2026 stood at $29.3 million (up 1.64% YoY), while the FY2025 annual figure was $28.9 million, up 1.23% from the prior year.
- Shares Outstanding (Weighted Average) came in at $29.3 million for Q1 2026 at Krystal Biotech, up from $28.9 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $29.3 million in Q1 2026 to a low of $25.1 million in Q1 2022.
- A 5-year average of $27.5 million and a median of $28.3 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
- Across the five-year window, Shares Outstanding (Weighted Average) gained 18.17% in 2022 and gained 1.23% in 2025, its largest moves.
- Krystal Biotech's Shares Outstanding (Weighted Average) stood at $25.5 million in 2022, then grew by 6.52% to $27.2 million in 2023, then gained by 5.3% to $28.6 million in 2024, then rose by 1.23% to $28.9 million in 2025, then grew by 1.19% to $29.3 million in 2026.
- According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $29.3 million, $28.9 million, and $29.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 177,333.76 Bn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 185,491.37 Bn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 100.00 Bn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 55.66 Bn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 254.10 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 16.04 Bn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 132.89 Mn |
| 10 | Krystal Biotech | 9.05 Bn | 8.23 Bn | 110.03 Mn | 29.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.29 Mn |
| Dec 31, 2025 | 28.94 Mn |
| Sep 30, 2025 | 28.95 Mn |
| Jun 30, 2025 | 28.86 Mn |
| Mar 31, 2025 | 28.82 Mn |
| Dec 31, 2024 | 28.59 Mn |
| Sep 30, 2024 | 28.54 Mn |
| Jun 30, 2024 | 28.45 Mn |
| Mar 31, 2024 | 28.30 Mn |
| Dec 31, 2023 | 27.15 Mn |
| Sep 30, 2023 | 28.04 Mn |
| Jun 30, 2023 | 26.66 Mn |
| Mar 31, 2023 | 25.71 Mn |
| Dec 31, 2022 | 25.49 Mn |
| Sep 30, 2022 | 25.62 Mn |
| Jun 30, 2022 | 25.55 Mn |
| Mar 31, 2022 | 25.11 Mn |
| Dec 31, 2021 | 22.20 Mn |
| Sep 30, 2021 | 22.21 Mn |
| Jun 30, 2021 | 21.73 Mn |
| Mar 31, 2021 | 21.25 Mn |
| Dec 31, 2020 | 18.79 Mn |
| Sep 30, 2020 | 19.68 Mn |
| Jun 30, 2020 | 18.38 Mn |
| Mar 31, 2020 | 17.36 Mn |
| Dec 31, 2019 | 15.90 Mn |
| Sep 30, 2019 | 15.42 Mn |
| Jun 30, 2019 | 14.47 Mn |
| Mar 31, 2019 | 14.42 Mn |
| Dec 31, 2018 | 11.20 Mn |
| Sep 30, 2018 | 10.42 Mn |
| Jun 30, 2018 | 10.31 Mn |
| Mar 31, 2018 | 10.31 Mn |
| Dec 31, 2017 | 5.36 Mn |
| Sep 30, 2017 | 4.18 Mn |
| Jun 30, 2017 | 3.49 Mn |
| Mar 31, 2017 | 3.49 Mn |
| Dec 31, 2016 | 877,490.00 |
| Sep 30, 2016 | 13,016.00 |